Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy: future therapy for erectile dysfunction.

G Schenk1, A Melman, G Christ

  • 1Institute for Smooth Muscle Biology, Department of Urology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. christ@aecom.yu.edu

Current Urology Reports
|June 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Triazolopyrimidine herbicides are potent inhibitors of Aspergillus fumigatus acetohydroxyacid synthase and potential antifungal drug leads.

Scientific reports·2021
Same author

[Female prostate cancer?]

Der Pathologe·2017
Same author

Product release is rate-limiting for catalytic processing by the Dengue virus protease.

Scientific reports·2016
Same author

Mechanisms of hemolysis-associated platelet activation.

Journal of thrombosis and haemostasis : JTH·2013
Same author

Animal models of erectile dysfunction (ED): potential utility of non-human primates as a model of atherosclerosis-induced vascular ED.

International journal of impotence research·2011
Same author

Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue.

International journal of impotence research·2010
Same journal

Effective Mentorship in Urology Fellowship Training: Qualities, Models, and Equity.

Current urology reports·2026
Same journal

Management of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis.

Current urology reports·2026
Same journal

Lower Urinary Tract Symptoms as an Indicator of Occult Neurologic Disease: A System-first Framework for Urologic Practice.

Current urology reports·2026
Same journal

Association Between Ambient Temperature and Urolithiasis: A Systematic Review and Meta-analysis.

Current urology reports·2026
Same journal

Is Open Partial Nephrectomy Still an Option in the Robotic Era?

Current urology reports·2026
Same journal

Artificial Intelligence in Urologic Documentation: A Review of Emerging Capabilities and the Ongoing Need for Human Oversight.

Current urology reports·2026
See all related articles

Gene therapy shows promise for treating erectile dysfunction by targeting numerous molecular pathways. Preclinical studies demonstrate significant success, suggesting potential for treating smooth muscle disorders.

Area of Science:

  • Molecular Biology
  • Urology
  • Regenerative Medicine

Background:

  • Advances in molecular biology and the Human Genome Project have paved the way for molecular medicine.
  • Extensive knowledge of erection physiology and erectile dysfunction pathophysiology exists.
  • Gene therapy for erectile dysfunction (ED) is now a distinct possibility.

Purpose of the Study:

  • To highlight the goals and strategies of gene therapy for ED.
  • To review the gene therapy strategies that have been employed.
  • To assess the potential of gene therapy for ED treatment.

Main Methods:

  • Review of preclinical gene therapy strategies and targets for ED.
  • Examination of in vivo and in vitro studies on gene therapy for ED.

Related Experiment Videos

  • Analysis of the physiological and pathophysiological mechanisms of ED.

    • Main Results:

    • Numerous physiologically relevant molecular targets for gene therapy exist for ED.
    • Preclinical gene therapy strategies have been largely successful in ameliorating compromised erectile function.
    • Data from preclinical studies are impressive and encouraging.

    Conclusions:

    • Gene therapy for ED is a viable therapeutic possibility.
    • Preclinical success suggests potential for clinical application.
    • Successful clinical trials could establish gene therapy for ED as a proof of concept for treating human smooth muscle disorders.